Buy 5-MAPB online | 5-MAPB vendor USA – What is 5-MAPB (5-(N-methyl-2-aminopropyl)benzofuran)?
5-MAPB, or 5-(N-methyl-2-aminopropyl)benzofuran, is a synthetic entactogen from the benzofuran class that sits close to MDMA and 6‑APB on the structural family tree. In simple terms, chemists view it as a ring-substituted amphetamine analogue that targets serotonin, norepinephrine and dopamine systems in experimental models. Buy 5-MAPB online
According to Wikipedia’s 5-MAPB entry and preclinical work cited there, 5-MAPB behaves as a serotonin–norepinephrine–dopamine releasing agent, with reported EC50 values in the low nanomolar range for monoamine release in rat brain synaptosomes. Experimental work in mice suggests pronounced increases in extracellular 5‑HT, DA and NE, along with clear hyperthermic and toxic responses at high doses.
At Davechemicals.com, we treat 5-MAPB research chemical as a specialist material reserved for trained professionals who understand the pharmacology, analytical handling and legal constraints involved.
chemical structure
![]()
Caption: Molecular structure illustration of 5-MAPB benzofuran entactogen for reference in analytical and pharmacology research.
How does 5-MAPB work pharmacologically?
Animal and in‑vitro data describe 5-MAPB as a monoamine releaser that pushes serotonin, norepinephrine and dopamine out of presynaptic neurons, similar in broad mechanism to MDMA but with its own profile. Studies referenced on DrugBank-style pharmacology summaries and Drugs.com scientific sections typically frame such agents as transporter substrates that reverse normal monoamine uptake.
According to the 5-MAPB pharmacology overview on Wikipedia, the compound also acts as a partial agonist at 5‑HT2A, 5‑HT2B and 5‑HT2C receptors, and a potent agonist at 5‑HT1B, which is relevant when researchers look at cardiovascular and neuropsychiatric safety markers. A Japanese toxicology study reported that 5‑MAPB produced large increases in extracellular 5‑HT, DA and NE, and was more lethal to mice at matched molar doses than MDMA, which underlines why this material sits firmly in the “for research only” category.
To complement 5-MAPB work, some laboratories also study related stimulants and entactogens such as 4-MeTMP (threo-4-methylmethylphenidate), 4-MPD powder and methylone crystals for comparative transporter assays and receptor binding panels.
Why do researchers study 5-MAPB?
On harm‑reduction platforms like PsychonautWiki’s 5-MAPB entry and Tripsitter’s empathogen guides, 5‑MAPB is described as an empathogenic compound with MDMA‑like and benzofuran‑typical effects. These community observations are not a substitute for formal data, but they do help toxicologists and epidemiologists track emerging trends in novel psychoactive substances.
The benzofuran group, including compounds such as 5‑APB and 6‑APB, has appeared repeatedly in forensic casework, prompting interest from analytical labs and public health agencies worldwide. As one paper on benzofuran toxicity notes, 5‑MAPB produced lethal intoxication in two‑thirds of mice at a particular high dose, whereas MDMA did not, which is a stark reminder that “similar structure” does not mean “similar safety”.
At Davechemicals.com, we position 5-MAPB benzofuran powder squarely as a reference standard for chromatographic, spectrometric and toxicological work, never as a product for human use or casual experimentation.
What is the legal status of 5-MAPB in the UK, USA, Germany, Australia and Asia? ⚖️
Legal status shifts frequently, and any serious lab performs its own legal review. Current open sources give a clear picture of how 5-MAPB is handled in several key regions. According to the 5-MAPB legal status section on Wikipedia and European regulatory summaries, the benzofuran family is widely controlled as part of national responses to novel psychoactive substances.
- United Kingdom
5-MAPB was first targeted by a Temporary Class Drug Order in 2013 and later became a Class B drug under the Misuse of Drugs Act, along with most benzofuran entactogens. - United States
5-MAPB does not have a specific federal listing, but due to close similarity to MDMA, it can fall under the Federal Analogue Act when intended for human consumption, and some states may apply additional scheduling. - Germany & wider EU
Papers on benzofuran control note that APB‑type substances sold as “Benzo Fury” were outlawed in the UK, Germany and Sweden as part of designer drug legislation. Many EU states now treat 5‑MAPB as a controlled substance or as part of generic catch‑all NPS bans. - Australia & Asia
Australian scheduling of MDMA analogues is strict, and 5‑MAPB sits in a grey or controlled area within “MDMA‑like substances” and NPS controls, while China added 5‑MAPB to its controlled substances list in 2015.
For these reasons, 5-MAPB for sale at Davechemicals.com is marketed strictly as “for research purposes, not for human consumption”, and every customer remains responsible for knowing and following their local law.
Table 1: Legal and research positioning of 5-MAPB
Regulatory & Research Overview for 5-MAPB
| Region / Context | Status summary* | Research positioning at Davechemicals.com | Notes on risk profile |
|---|---|---|---|
| United Kingdom | Controlled as Class B drug under benzofuran umbrella. | Available only to vetted research clients. | Strong monoamine release and toxicity signal in animal data. |
| European Union (general) | Often scheduled or covered by NPS frameworks. | Shipped only where local regulations allow research use. | Forensic interest due to appearance in NPS markets. |
| United States | Potential analogue of MDMA under Analogue Act. | Sold strictly for non‑human laboratory work. | Legal risk if misused as human drug. |
| Australia | Likely treated as MDMA‑like NPS under strict controls. | Not supplied where domestic controls prohibit import. | High caution due to public health focus. |
| Asia (incl. China) | China lists 5‑MAPB as controlled since 2015. | Only shipped to jurisdictions where lawful. | Regulatory trend is toward tighter control. |

